MYOS - ミオス (MYOS RENS Technology Inc.)

MYOSのニュース

   85 Stocks Moving In Wednesday's Mid-Day Session  2020/08/05 12:02:00 Benzinga
Gainers Biofrontera AG (NASDAQ: BFRA) climbed 151.8% to $14.10. MYOS RENS Technology Inc. (NASDAQ: MYOS) shares climbed 73.4% to $2.15 after the company …
   MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020  2020/08/05 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., Aug. 5, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announces its results for the three and six…
   MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.  2020/07/16 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., July 16, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced…
   SHAREHOLDER ALERT: WeissLaw LLP Investigates MYOS RENS Technology Inc.  2020/07/08 01:30:00 PR Newswire
NEW YORK, July 7, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) in connection with the proposed merger of the Company with…
   University of California, Berkeley Researchers Publish Clinical Results Reporting that Fortetropin® Increased the Rate of Muscle Protein Synthesis in Older Adults  2020/07/07 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., July 7, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle,…
   85 Stocks Moving In Wednesday's Mid-Day Session  2020/08/05 12:02:00 Benzinga
Gainers Biofrontera AG (NASDAQ: BFRA) climbed 151.8% to $14.10. MYOS RENS Technology Inc. (NASDAQ: MYOS) shares climbed 73.4% to $2.15 after the company …
   MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020  2020/08/05 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., Aug. 5, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announces its results for the three and six…
   MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.  2020/07/16 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., July 16, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced…
   SHAREHOLDER ALERT: WeissLaw LLP Investigates MYOS RENS Technology Inc.  2020/07/08 01:30:00 PR Newswire
NEW YORK, July 7, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) in connection with the proposed merger of the Company with…
   University of California, Berkeley Researchers Publish Clinical Results Reporting that Fortetropin® Increased the Rate of Muscle Protein Synthesis in Older Adults  2020/07/07 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., July 7, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle,…
   85 Stocks Moving In Wednesday's Mid-Day Session  2020/08/05 12:02:00 Benzinga
Gainers Biofrontera AG (NASDAQ: BFRA) climbed 151.8% to $14.10. MYOS RENS Technology Inc. (NASDAQ: MYOS) shares climbed 73.4% to $2.15 after the company …
   MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020  2020/08/05 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., Aug. 5, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announces its results for the three and six…
   MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.  2020/07/16 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., July 16, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced…
   SHAREHOLDER ALERT: WeissLaw LLP Investigates MYOS RENS Technology Inc.  2020/07/08 01:30:00 PR Newswire
NEW YORK, July 7, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) in connection with the proposed merger of the Company with…
   University of California, Berkeley Researchers Publish Clinical Results Reporting that Fortetropin® Increased the Rate of Muscle Protein Synthesis in Older Adults  2020/07/07 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., July 7, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle,…

calendar